Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: Complete Statistical AnalysisIndependent statistical analysis of A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A-TREATIndependent statistical analysis of American Trial Using Tranexamic Acid in Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02578901).
- AAA CEUSIndependent statistical analysis of Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu’s Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ABATEIndependent statistical analysis of Active Bathing to Eliminate Infection (ABATE Infection) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063867).
- ABCIndependent statistical analysis of Arrythmia Burden in Cardiac Contractility Modulation (CCM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05704426).
- ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: Complete Statistical AnalysisIndependent statistical analysis of ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ablate-NCSIndependent statistical analysis of Cardioneuroablation for Neurocardiogenic Syncope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02009982).
- ABSORB EXTENDIndependent statistical analysis of ABSORB EXTEND Clinical Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01023789).
- Absorb IV Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Absorb IV Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02173379).
- Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: Complete Statistical AnalysisIndependent statistical analysis of Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AC105Independent statistical analysis of AC105 in Patients With Acute Traumatic Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01750684).
- Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: Complete Statistical AnalysisIndependent statistical analysis of Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00519779).
- Acamprosate to Reduce Symptoms of Alcohol Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate to Reduce Symptoms of Alcohol Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00106106).
- Acamprosate vs. Placebo in Bipolar Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate vs. Placebo in Bipolar Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466661).
- Accelerated Tooth Movement With AcceleDent® and Aligners – a Pilot Project: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Accent CardiacIndependent statistical analysis of Accent Cardiac MRI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02041702).
- Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661840).
- ACCESSIndependent statistical analysis of ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ACCESS IIndependent statistical analysis of Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients: Complete Statistical AnalysisIndependent statistical analysis of ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01867047).
- ACESIndependent statistical analysis of ASPIRE Cognitive Enhancement Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02657954).
- Acetaminophen Before Vaccines for Infants Study (AVIS): Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen Before Vaccines for Infants Study (AVIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00325819).
- Acetazolamide Efficacy in Ataxia in PMM2-CDG: Complete Statistical AnalysisIndependent statistical analysis of Acetazolamide Efficacy in Ataxia in PMM2-CDG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04679389).
- Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ACHIEVEIndependent statistical analysis of Albumin for Intracerebral Hemorrhage Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00990509).
- ACHIEVEIndependent statistical analysis of Randomized Trial Of Achieving Healthy Lifestyles In Psych Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902694).
- ACHIEVE-HIFUIndependent statistical analysis of ACHIEVE Hearing Intervention Follow-Up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05070429).
- ACLIndependent statistical analysis of Ocular Adaptation and Visual Performance for Accommodative Contact Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02923232).
- AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: Complete Statistical AnalysisIndependent statistical analysis of AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126187).
- ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: Complete Statistical AnalysisIndependent statistical analysis of ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ACT IIndependent statistical analysis of Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I): primary endpoint results,…
- ACTH Gel Therapy in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of ACTH Gel Therapy in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02030028).
- Acthar Gel for Active Systemic Lupus Erythematosus (SLE): Complete Statistical AnalysisIndependent statistical analysis of Acthar Gel for Active Systemic Lupus Erythematosus (SLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02953821).
- Actigraphic Analysis of Treatment Response: Complete Statistical AnalysisIndependent statistical analysis of Actigraphic Analysis of Treatment Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00723580).
- ACTIONIndependent statistical analysis of Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ACTIONIndependent statistical analysis of Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24…
- ACTIV-6: COVID-19 Study of Repurposed Medications: Complete Statistical AnalysisIndependent statistical analysis of ACTIV-6: COVID-19 Study of Repurposed Medications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04885530).
- Active and Passive Music Therapy Interventions: Complete Statistical AnalysisIndependent statistical analysis of Active and Passive Music Therapy Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03362944).
- Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval,…
- ActiveCOPDIndependent statistical analysis of Active for Life: Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03201198).
- Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002): Complete Statistical AnalysisIndependent statistical analysis of Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Acupressure in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Acupressure in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05412121).
- Acupuncture ACL (Anterior Cruciate Ligament): Complete Statistical AnalysisIndependent statistical analysis of Acupuncture ACL (Anterior Cruciate Ligament): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03711734).
- Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Acute and Residual Effects of Caffeinated Beer: Complete Statistical AnalysisIndependent statistical analysis of Acute and Residual Effects of Caffeinated Beer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515294).